Episode 162: Oral vs transdermal estrogen and risk of blood clot

episode

Sky Women's Health not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from Sky Women's Health

Episode 233: At-Home HPV Testing: Promise or Peril in a New Screening Era 36 min · 21 Dec 2025

All episodes from Sky Women's Health →

Report any issue

Source

Recorded28 Jan 2024

Publisherfeeds.captivate.fm ↗

Handlerec:8136875

Show notes

Which route is right for you? Nonoral delivery systems of estradiol bypass the first pass effect. While oral estrogen therapy has been associated with increased factors the cause blood clots, transdermal estrogen appears to have a suppressive effect on these markers. Postmenopausal estrogen therapy involves a nuanced understanding of the mode of administration, individual risk factors, and the latest research findings. Seek a menopause society certified practioner (MSCP) in your area. **This is not medical advice, just medical education. Please ask your doctor medical questions as they pertain to your specific situation. Educational purposes only. .......................................................................... Welcome to the Sky Women community where we are all stronger together. COME SAY HI!!! Instagram: https://www.instagram.com/skywomenshealth https://www.instagram.com/drcarolynmoyers Facebook: https://www.facebook.com/skywomenshealth Email: [email protected] Sky Women’s Health: Https://www.skywomenshealth.com 1125 S Henderson St, Fort Worth, TX 76104 To become a patient: email [email protected] or call 817-915-9803. #EstrogenSafety #HormoneTherapyInsights #BloodClotRisk #TransdermalvsOral #MenopauseHealth #HormoneDeliverySystems #ACOGGuidelines #WomenHealthPodcast #skywomenshealth

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.